Comparison Between Two Different Diets in Children and Adolecents with Cystic Fibrosis

The Comparison Between High Calorie,High Fat Diets with Different Glycemic Indexes on Some Biomarkers Related to Diabetes and Oxidative Stress in Children and Adolecents with Cystic Fibrosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015112825267N1

Enrollment

Registered

2017-05-21

Start date

2016-09-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystic fibrosis. cystic fibrosis

Interventions

Intervention 1: Intervention group: Following High fat , High calorie diet with low gycemic index for three months. Intervention 2: control: Following high fat , high calorie diet for three months.

Prevention

Intervention group: Following High fat , High calorie diet with low gycemic index for three months

control: Following high fat , high calorie diet for three months

Eligibility

Sex/Gender

All

Age

2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children and adolescents aged 2-18; children and adolescents who affected disease is confirmed by genetic or sweat test; willingness to cooperate Exclusion criteria: unwilling to cooperate and continue; inability to pursue each types of the diet; urgent need of hospitalization during trial; urgent need of operation during trial

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insulin. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;Fasting blood glucose. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;HDL cholostrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: measurement of variables blood level biochemically.;LDL cholestrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: biochemical measurement.;MDA. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;RBP4. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;HbA1c. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;Total cholestrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: biochemical measurement.	—

Measure

Time frame

Insulin. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;Fasting blood glucose. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;HDL cholostrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: measurement of variables blood level biochemically.;LDL cholestrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: biochemical measurement.;MDA. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;RBP4. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;HbA1c. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: ELISA Kit.;Total cholestrol. Timepoint: pre intervention and 3 months after begining the diet. Method of measurement: biochemical measurement.

—

Secondary

Measure	Time frame
Height. Timepoint: begining of the trial and three months after. Method of measurement: meter.;Weight. Timepoint: begining of the trial and three months after. Method of measurement: Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloufar Arabzadegan

Tehran University of Medical Sciences

niloufar.arabzadegan@gmail.com+98 913 745 1805

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026